At Optoceutics, we are committed to developing cutting-edge technologies to help fight neurodegenerative diseases and mental health disorders.
We work at the intersection of neuroscience, engineering and informatics to create preventive health solutions that are safe, non-invasive and custom-care.
❚ Investigating Gamma Brain Waves for Alzheimer’s Disease
Optoceutics is currently conducting a clinical study to investigate the potential effect of masked 40 Hz flickering light on Alzheimer’s disease patients.
DISCLAIMER: All devices used in trials are considerd investigational devices and limited to investigational use only.
Sign-up to our newsletter and receive new information about our developments, clinical trials and more.
❚ Selected Partners
❚ Latest News
TV2 Lorry has followed us for a long time in connection with our participation in the Danish Tech Challenge.